Rhumbline Advisers Genfit S.A. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Genfit S.A. stock. As of the latest transaction made, Rhumbline Advisers holds 678 shares of GNFT stock, worth $2,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
678
Previous 678
-0.0%
Holding current value
$2,847
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GNFT
# of Institutions
5Shares Held
77.7KCall Options Held
0Put Options Held
0-
Optiver Holding B.V. Amsterdam, P751.8KShares$217,5510.01% of portfolio
-
Morgan Stanley New York, NY25KShares$105,0840.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ250Shares$1,0500.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $209M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...